Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus.


Journal

Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420

Informations de publication

Date de publication:
11 07 2019
Historique:
pubmed: 13 2 2019
medline: 6 8 2020
entrez: 13 2 2019
Statut: ppublish

Résumé

The finding that most grades II and III gliomas harbor isocitrate dehydrogenase (IDH) mutations conveying a relatively favorable and fairly similar prognosis in both tumor grades highlights that these tumors represent a fundamentally different entity from IDH wild-type gliomas exemplified in most glioblastoma. Herein we review the most recent developments in molecular neuropathology leading to reclassification of these tumors based upon IDH and 1p/19q status, as well as the potential roles of methylation profiling and deletional analysis of cyclin-dependent kinase inhibitor 2A and 2B. We discuss the epidemiology, clinical manifestations, benefit of surgical resection, and neuroimaging features of lower-grade gliomas as they relate to molecular subtype, including advanced imaging techniques such as 2-hydroxyglutarate magnetic resonance spectroscopy and amino acid PET scanning. Recent, ongoing, and planned studies of radiation therapy and both cytotoxic and targeted chemotherapies are summarized, including both small molecule and immunotherapy approaches specifically targeting the mutant IDH protein.

Identifiants

pubmed: 30753579
pii: 5310249
doi: 10.1093/neuonc/noz033
pmc: PMC6620638
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

837-853

Subventions

Organisme : NCI NIH HHS
ID : P50 CA211015
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Neuro Oncol. 2019 Feb 14;21(2):179-188
pubmed: 30321384
Acta Neuropathol. 2017 Apr;133(4):629-644
pubmed: 28124097
Lancet Neurol. 2009 Sep;8(9):810-8
pubmed: 19665931
Neuro Oncol. 2018 Jan 10;20(1):103-112
pubmed: 29016833
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8388-E8394
pubmed: 30082399
Neurosurgery. 2012 Jan;70(1):234-43; discussion 243-4
pubmed: 21593697
Nat Genet. 2012 Oct;44(10):1122-5
pubmed: 22922872
Brain Pathol. 2002 Apr;12(2):257-9
pubmed: 11958379
Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1175-83
pubmed: 15964709
Br J Cancer. 2011 Feb 15;104(4):545-53
pubmed: 21119666
Eur J Radiol. 2010 Feb;73(2):215-20
pubmed: 19201123
J Neurosurg. 2018 Mar;128(3):800-810
pubmed: 28362239
Neuro Oncol. 2012 Sep;14 Suppl 4:iv55-64
pubmed: 23095831
J Neurooncol. 2017 Aug;134(1):9-18
pubmed: 28567586
J Clin Oncol. 2007 Dec 20;25(36):5723-30
pubmed: 18089866
Ann Neurol. 2007 May;61(5):484-90
pubmed: 17469128
N Engl J Med. 2016 Apr 7;374(14):1344-55
pubmed: 27050206
Neuro Oncol. 2016 Nov;18(11):1529-1537
pubmed: 27370396
J Clin Oncol. 1994 Oct;12(10):2013-21
pubmed: 7931469
J Neurooncol. 2015 Jan;121(2):365-72
pubmed: 25344884
Acta Neuropathol. 2010 Sep;120(3):297-304
pubmed: 20644945
J Clin Oncol. 2013 Jan 20;31(3):337-43
pubmed: 23071247
Neurosurgery. 2014 Apr;74(4):339-48; discussion 349; quiz 349-50
pubmed: 24368543
Lancet. 2005 Sep 17-23;366(9490):985-90
pubmed: 16168780
Lancet. 2017 Oct 7;390(10103):1645-1653
pubmed: 28801186
Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
Chin J Cancer. 2014 Jan;33(1):40-5
pubmed: 24384239
Brain Pathol. 2014 Sep;24(5):429-35
pubmed: 24990071
Sci Transl Med. 2012 Jan 11;4(116):116ra4
pubmed: 22238332
Neuro Oncol. 2001 Jul;3(3):193-200
pubmed: 11465400
Cancer Cell. 2010 Mar 16;17(3):225-34
pubmed: 20171147
Lancet Oncol. 2016 Nov;17(11):1521-1532
pubmed: 27686946
J Neurosurg. 2011 Aug;115(2):232-9
pubmed: 21548750
J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9
pubmed: 9776413
Acta Neuropathol. 2014 Oct;128(4):561-71
pubmed: 25008768
Cancer. 2009 Apr 15;115(8):1734-43
pubmed: 19197992
J Clin Oncol. 2014 Feb 20;32(6):535-41
pubmed: 24419119
Cochrane Database Syst Rev. 2017 Apr 27;4:CD009319
pubmed: 28447767
Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):527-33
pubmed: 8655376
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
J Clin Oncol. 2015 Jul 1;33(19):2166-75
pubmed: 26014298
Neuro Oncol. 2014 Sep;16(9):1244-54
pubmed: 24723566
Neuro Oncol. 2017 Nov 6;19(suppl_5):v1-v88
pubmed: 29117289
Cancer Res. 2017 Apr 1;77(7):1709-1718
pubmed: 28202508
Lancet Oncol. 2018 Sep;19(9):1170-1179
pubmed: 30115593
J Clin Oncol. 2002 May 1;20(9):2267-76
pubmed: 11980997
Lancet Oncol. 2016 Nov;17(11):1533-1542
pubmed: 27686943
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):662-9
pubmed: 19783377
Ann Neurol. 2010 Nov;68(5):727-33
pubmed: 21031584
J Neurooncol. 2016 Nov;130(2):269-282
pubmed: 27174197
AJNR Am J Neuroradiol. 2008 Sep;29(8):1505-10
pubmed: 18556364
Neuro Oncol. 2017 Feb 1;19(2):242-251
pubmed: 27571885
J Clin Oncol. 2015 Mar 20;33(9):1023-9
pubmed: 25667287
Neurosurgery. 2009 Sep;65(3):463-9; discussion 469-70
pubmed: 19687690
Neuro Oncol. 2017 Oct 1;19(10):1327-1337
pubmed: 28575485
Annu Rev Pathol. 2017 Jan 24;12:515-545
pubmed: 28068482
CNS Oncol. 2018 Apr;7(2):CNS16
pubmed: 29378419
AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2466-74
pubmed: 16286386
J Neurosurg. 2014 Feb;120(2):309-14
pubmed: 24313617
Neurology. 2000 Apr 11;54(7):1442-8
pubmed: 10751254
J Neurooncol. 2015 Apr;122(2):329-38
pubmed: 25563816
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
J Clin Oncol. 2008 Mar 10;26(8):1338-45
pubmed: 18323558
N Engl J Med. 2015 Jun 25;372(26):2499-508
pubmed: 26061753
Neurology. 2004 Sep 14;63(5):904-6
pubmed: 15365146
Nature. 2009 Dec 10;462(7274):739-44
pubmed: 19935646
Nature. 2014 Aug 21;512(7514):324-7
pubmed: 25043048
J Neurooncol. 2014 Jan;116(1):161-8
pubmed: 24162809
Science. 2013 May 3;340(6132):626-30
pubmed: 23558169
Cancer. 1997 Apr 1;79(7):1381-93
pubmed: 9083161
Blood. 2017 Aug 10;130(6):722-731
pubmed: 28588020
Neuro Oncol. 2011 Feb;13(2):235-41
pubmed: 21177338
Lancet. 2002 Nov 2;360(9343):1361-8
pubmed: 12423981
Cancer Cell. 2015 Dec 14;28(6):773-784
pubmed: 26678339
J Neurosurg. 2015 Aug;123(2):325-39
pubmed: 25909573
Radiology. 2008 Apr;247(1):170-8
pubmed: 18372467
Acta Neuropathol. 2018 Jul;136(1):153-166
pubmed: 29687258
Acta Neuropathol. 2014 Oct;128(4):551-9
pubmed: 25143301
J Clin Oncol. 2014 Mar 10;32(8):783-90
pubmed: 24516018
Acta Neuropathol. 2015 Jun;129(6):867-73
pubmed: 25962792
J Neurosurg. 2014 Nov;121(5):1115-23
pubmed: 25192475
Ann Oncol. 2003 Apr;14(4):599-602
pubmed: 12649108
Cancer Cell. 2018 Aug 13;34(2):186-195
pubmed: 29805076
Epilepsy Res. 2015 Jan;109:100-5
pubmed: 25524848
Neurology. 2009 May 5;72(18):1601-6
pubmed: 19414728
Eur J Cancer. 2006 Oct;42(15):2499-503
pubmed: 16914310
N Engl J Med. 2017 Nov 16;377(20):1954-1963
pubmed: 29141164
Lancet Oncol. 2005 Dec;6(12):937-44
pubmed: 16321761
Eur J Cancer. 2018 Jan;88:109-114
pubmed: 29239741
Science. 2011 Sep 9;333(6048):1453-5
pubmed: 21817013
Cell. 2016 Jan 28;164(3):550-63
pubmed: 26824661
Neuro Oncol. 2017 Oct 1;19(10):1380-1390
pubmed: 28472509
Neurosurgery. 2012 Apr;70(4):921-8; discussion 928
pubmed: 21997540
N Engl J Med. 2014 Feb 20;370(8):699-708
pubmed: 24552317
J Neurooncol. 2009 Feb;91(3):359-67
pubmed: 18953491
Neuro Oncol. 2017 Feb 1;19(2):252-258
pubmed: 27994066
J Neuropathol Exp Neurol. 2001 Mar;60(3):248-62
pubmed: 11245209
Cancer. 2017 Dec 1;123(23):4631-4639
pubmed: 28759109
Sci Rep. 2016 Aug 30;6:32286
pubmed: 27574036
Acta Neuropathol. 2017 Dec;134(6):957-959
pubmed: 29052002
Neurosurgery. 1998 Nov;43(5):1066-73
pubmed: 9802850
Neuro Oncol. 2014 Jan;16(1):81-91
pubmed: 24305719
Radiology. 2009 Nov;253(2):505-12
pubmed: 19789244
Nat Rev Neurol. 2017 Jun;13(6):340-351
pubmed: 28497806
Nat Med. 2012 Jan 26;18(4):624-9
pubmed: 22281806
Neuro Oncol. 2013 May;15(5):595-606
pubmed: 23393207
Neurooncol Pract. 2016 Mar;3(1):10-16
pubmed: 26941959
Sci Transl Med. 2017 Feb 1;9(375):
pubmed: 28148839
N Engl J Med. 2008 Jan 3;358(1):18-27
pubmed: 18172171
Neuro Oncol. 2014 Aug;16(8):1100-9
pubmed: 24847087
Nat Genet. 2015 May;47(5):458-68
pubmed: 25848751
Ann Neurol. 1988 Apr;23(4):360-4
pubmed: 3382171
J Neuropathol Exp Neurol. 2006 Oct;65(10):988-94
pubmed: 17021403
Nat Med. 2018 Aug;24(8):1192-1203
pubmed: 29988124
J Clin Oncol. 1999 Sep;17(9):2762-71
pubmed: 10561351
J Neurooncol. 2018 Feb;136(3):533-539
pubmed: 29143276
Neuro Oncol. 2011 Jun;13(6):649-59
pubmed: 21636710
Neuro Oncol. 2016 Feb;18(2):283-90
pubmed: 26691210
Eur J Neurol. 2010 Sep;17(9):1124-33
pubmed: 20718851
Nat Commun. 2018 Apr 16;9(1):1474
pubmed: 29662077
Cell. 2018 Jan 11;172(1-2):90-105.e23
pubmed: 29249359
Clin Cancer Res. 2008 Nov 1;14(21):7068-73
pubmed: 18981004
Neuro Oncol. 2004 Oct;6(4):300-5
pubmed: 15494097
Strahlenther Onkol. 2000 Jun;176(6):259-64
pubmed: 10897252
J Neurosurg. 2011 Aug;115(2):240-4
pubmed: 21529134
Cancer Cell. 2006 Mar;9(3):157-73
pubmed: 16530701
Ann Neurol. 2011 Mar;69(3):455-63
pubmed: 21446021
Cancer. 2018 Jul 1;124(13):2674-2676
pubmed: 29698549
J Neurooncol. 2017 Mar;132(1):145-153
pubmed: 28150189
Neuro Oncol. 2003 Jul;5(3):161-7
pubmed: 12816722
Neuro Oncol. 2015 Nov;17(11):1434-44
pubmed: 26130743
Neurology. 2017 May 9;88(19):1805-1813
pubmed: 28404805
Eur J Cancer. 2008 Jun;44(9):1210-6
pubmed: 18248979
Neuro Oncol. 2016 May;18(5):744-51
pubmed: 26578622
N Engl J Med. 2009 Feb 19;360(8):765-73
pubmed: 19228619
Acta Neuropathol. 2015 Apr;129(4):585-96
pubmed: 25701198
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):549-56
pubmed: 8948338
JAMA. 2012 Nov 14;308(18):1881-8
pubmed: 23099483
N Engl J Med. 2015 Jun 25;372(26):2481-98
pubmed: 26061751
J Clin Oncol. 2003 Jul 1;21(13):2525-8
pubmed: 12829671
J Neurooncol. 2016 Sep;129(2):319-28
pubmed: 27344556
World Neurosurg. 2017 Mar;99:751-757
pubmed: 27108796
J Neurooncol. 2005 Feb;71(3):319-23
pubmed: 15735924
Cancer Res. 2006 Oct 15;66(20):9852-61
pubmed: 17047046
Clin Cancer Res. 2016 Apr 1;22(7):1632-41
pubmed: 26534967
Eur J Radiol. 2009 Oct;72(1):54-64
pubmed: 18632238
Science. 2014 Jan 10;343(6167):189-193
pubmed: 24336570
Clin Cancer Res. 2013 Oct 1;19(19):5513-22
pubmed: 23948976
JAMA. 2005 Feb 2;293(5):557-64
pubmed: 15687310
J Neurosurg. 2012 Feb;116(2):365-72
pubmed: 21999317
J Clin Oncol. 2013 Jan 20;31(3):344-50
pubmed: 23071237
N Engl J Med. 2014 Feb 20;370(8):709-22
pubmed: 24552318
Cancer. 2015 May 15;121(10):1712-9
pubmed: 25585890

Auteurs

David Schiff (D)

Department of Neurology, University of Virginia, Charlottesville, Virginia.

Martin Van den Bent (M)

Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Michael A Vogelbaum (MA)

Department of Neurological Surgery, Cleveland Clinic, Cleveland, Ohio.

Wolfgang Wick (W)

Divison of Neuro-Oncology, German Cancer Research Center, Heidelberg, Germany.

C Ryan Miller (CR)

Pathology and Lab Medicine, University of North Carolina, Chapel Hill, North Carolina.

Martin Taphoorn (M)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Whitney Pope (W)

Section of Neuroradiology, UCLA, Los Angeles, California.

Paul D Brown (PD)

Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.

Michael Platten (M)

Department of Neurology, Mannheim University Hospital, Mannheim, Germany.

Rakesh Jalali (R)

Apollo Proton Cancer Centre, Chennai, India.

Terri Armstrong (T)

Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland.

Patrick Y Wen (PY)

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH